Holen Sie sich die Stockscreener-App
17.80
0.00%
0.00
Handel nachbörslich:
17.80
Schlusskurs vom Vortag:
$17.80
Offen:
$18
24-Stunden-Volumen:
3,531
Relative Volume:
4.74
Marktkapitalisierung:
$N/A
Einnahmen:
$1.96M
Nettoeinkommen (Verlust:
$-9.40M
KGV:
-1.0262
EPS:
-17.346
Netto-Cashflow:
$-6.31M
1W Leistung:
+69.85%
1M Leistung:
+78.00%
6M Leistung:
+263.27%
1J Leistung:
+14.04%
1-Tages-Spanne:
$13.47
$18.00
1-Wochen-Bereich:
$13.47
$18.00
52-Wochen-Spanne:
$0.0001
$18.00
Opgen Inc Stock (OPGN) Company Profile
Vergleichen Sie OPGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPGN
Opgen Inc
|
17.80 | 0 | 1.96M | -9.40M | -6.31M | -17.35 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Opgen Inc Stock (OPGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-03-01 | Eingeleitet | Alliance Global Partners | Buy |
| 2018-02-07 | Bestätigt | H.C. Wainwright | Buy |
| 2016-06-29 | Eingeleitet | Rodman & Renshaw | Buy |
Opgen Inc Aktie (OPGN) Neueste Nachrichten
OpGen Inc. (OPGN) Stock Price | Live Quotes & Charts | OTO - StocksToTrade
Infection Surveillance Solutions Market 2025 Forecast: - openPR.com
OpGen amends financing deal and announces president’s resignation - MSN
OpGen extends equity purchase agreement and announces president’s resignation By Investing.com - Investing.com Australia
OpGen extends equity purchase agreement and announces president’s resignation - Investing.com India
OpGen Inc Announces Resignation of President - TradingView — Track All Markets
OpGen (OPGN) prolongs $9.0M stock sale deal, President Lazar to resign - Stock Titan
Is OpGen Inc. (6500) stock resilient in recession scenariosGap Up & Verified Entry Point Detection - Улправда
Syndromic Multiplex Diagnostics Market Size to Hit USD 4.13 - GlobeNewswire
OpGen Delays Filing of Quarterly Report - MSN
OpGen (OTC:OPGN) Share Price Passes Above Fifty Day Moving AverageShould You Sell? - MarketBeat
OpGen Appoints New CEO Christian-Laurent Bonte - The Globe and Mail
OpGen appoints Christian-Laurent Bonte as chief executive officer By Investing.com - Investing.com Nigeria
OpGen appoints Christian-Laurent Bonte as chief executive officer - Investing.com
OpGen (OPGN) appoints Christian-Laurent Bonte as CEO with performance-based pay - Stock Titan
OpGen, Inc. Announces Chief Executive Officer Changes, Effective December 1, 2025 - marketscreener.com
Will OpGen Inc. (6500) stock maintain strong growth2025 Sector Review & Community Shared Stock Ideas - Newser
How OpGen Inc. (6500) stock reacts to stronger dollarWeekly Risk Summary & Proven Capital Preservation Tips - Newser
Why OpGen Inc. (6500) stock could break out in 2025Day Trade & AI Driven Stock Price Forecasts - Newser
Why OpGen Inc. (6500) stock is listed among top recommendations2025 Price Targets & AI Forecast Swing Trade Picks - Newser
Tangible book value per share of OpGen, Inc. – OTC:OPGN - TradingView
Will OpGen Inc. (6500) stock profit from fiscal stimulusJuly 2025 Fed Impact & High Accuracy Investment Signals - Newser
Working capital per share of OpGen, Inc. – LSE:0A8L - TradingView
Syndromic Multiplex Diagnostics Market to Reach USD 4.13 Billion by 2032, Growing at 4.71% CAGR as Demand for Rapid Multidisease Testing Surges - industrytoday.co.uk
OpGen (OTC:OPGN) Stock Price Crosses Above 50-Day Moving Average – Here’s Why - Defense World
Is OpGen Inc 6500 a good long term investmentBlue Chip Stock Analysis & Join 100,000+ Investors Already Learning - earlytimes.in
Why OpGen Inc. (6500) stock appears on watchlistsJuly 2025 Macro Moves & Free Daily Entry Point Trade Alerts - newser.com
Is OpGen Inc. (6500) stock a fit for income portfoliosJuly 2025 Reactions & High Yield Stock Recommendations - newser.com
OPGEN INC SEC 10-Q Report - TradingView
OpGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - marketscreener.com
OPGN SEC FilingsOpgen 10-K, 10-Q, 8-K Forms - Stock Titan
Is OpGen Inc. (6500) stock a good hedge against inflationPortfolio Value Summary & Low Risk High Reward Trade Ideas - newser.com
Why Misquita Engineering Limited Stock May Be a Hidden Gem in YEARCash Flow Trends & Invest With Confidence - earlytimes.in
Is OpGen Inc. (6500) stock a top dividend aristocrat candidate2025 Earnings Surprises & Low Risk Entry Point Guides - newser.com
How risky is OpGen Inc. (6500) stock compared to peersEarnings Overview Summary & Daily Profit Maximizing Tips - newser.com
Finanzdaten der Opgen Inc-Aktie (OPGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
0.51%
Kapitalisierung:
|
Volumen (24h):